315 related articles for article (PubMed ID: 36307871)
1. Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis.
Dai R; Liu M; Xiang X; Xi Z; Xu H
J Exp Clin Cancer Res; 2022 Oct; 41(1):316. PubMed ID: 36307871
[TBL] [Abstract][Full Text] [Related]
2. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.
Lawson MA; McDonald MM; Kovacic N; Hua Khoo W; Terry RL; Down J; Kaplan W; Paton-Hough J; Fellows C; Pettitt JA; Neil Dear T; Van Valckenborgh E; Baldock PA; Rogers MJ; Eaton CL; Vanderkerken K; Pettit AR; Quinn JM; Zannettino AC; Phan TG; Croucher PI
Nat Commun; 2015 Dec; 6():8983. PubMed ID: 26632274
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches to target the microenvironment of bone metastasis.
Hofbauer LC; Bozec A; Rauner M; Jakob F; Perner S; Pantel K
Nat Rev Clin Oncol; 2021 Aug; 18(8):488-505. PubMed ID: 33875860
[TBL] [Abstract][Full Text] [Related]
4. Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.
Hu W; Zhang L; Dong Y; Tian Z; Chen Y; Dong S
Cell Mol Life Sci; 2020 Dec; 77(24):5149-5169. PubMed ID: 32556373
[TBL] [Abstract][Full Text] [Related]
5. Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy.
Sai B; Xiang J
J Cell Mol Med; 2018 Dec; 22(12):5776-5786. PubMed ID: 30255991
[TBL] [Abstract][Full Text] [Related]
6. The bone microenvironment in metastasis; what is special about bone?
Bussard KM; Gay CV; Mastro AM
Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
[TBL] [Abstract][Full Text] [Related]
7. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell Colonisation in the Bone Microenvironment.
Kan C; Vargas G; Pape FL; Clézardin P
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782035
[TBL] [Abstract][Full Text] [Related]
9. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.
Cox TR; Rumney RMH; Schoof EM; Perryman L; Høye AM; Agrawal A; Bird D; Latif NA; Forrest H; Evans HR; Huggins ID; Lang G; Linding R; Gartland A; Erler JT
Nature; 2015 Jun; 522(7554):106-110. PubMed ID: 26017313
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
11. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
Kreps LM; Addison CL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
[TBL] [Abstract][Full Text] [Related]
12. The osteoblast in regulation of tumor cell dormancy and bone metastasis.
Zarrer J; Taipaleenmäki H
J Bone Oncol; 2024 Apr; 45():100597. PubMed ID: 38550395
[TBL] [Abstract][Full Text] [Related]
13. Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.
Shupp AB; Kolb AD; Mukhopadhyay D; Bussard KM
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29867053
[TBL] [Abstract][Full Text] [Related]
14. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
Quayle L; Ottewell PD; Holen I
Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
[TBL] [Abstract][Full Text] [Related]
15. Bone secreted factors induce cellular quiescence in prostate cancer cells.
Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
Yoneda T; Hiraga T
Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
[TBL] [Abstract][Full Text] [Related]
17. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
18. Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.
Widner DB; Park SH; Eber MR; Shiozawa Y
Curr Osteoporos Rep; 2018 Oct; 16(5):596-602. PubMed ID: 30128835
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional in Vitro Model to Study Osteobiology and Osteopathology.
Krishnan V; Vogler EA; Mastro AM
J Cell Biochem; 2015 Dec; 116(12):2715-23. PubMed ID: 26039562
[TBL] [Abstract][Full Text] [Related]
20. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
Guise TA; Mohammad KS; Clines G; Stebbins EG; Wong DH; Higgins LS; Vessella R; Corey E; Padalecki S; Suva L; Chirgwin JM
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6213s-6216s. PubMed ID: 17062703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
